Scientist might have found a way to stop allergic reactions. Researchers from Denmark successfully blocked the allergy-causing antibody known as Immunoglobulin E (IgE) from latching on to immune receptors, by using a competitor antibody known as 026 stab.
When you’re exposed to a benign substance (like cat saliva or pollen) your body mass produces IgE, which binds to immune receptors, releasing histamine — the chemical that causes your sniffles and dry eyes. The most popular allergy treatment is antihistamines, which target histamine, but not the antibodies that produce histamine in the first place.
Scientists tested the treatment on the blood of people who are allergic to birch pollen and insect venom. Then induced an allergic reaction and introduced 026 stab (the competitor antibody.) Within 15 minutes of the treatment, IgE levels decreased to 30% from the starting amount. The levels continued to decrease as treatment continued.
Before it can be implemented to the public, the treatment must undergo rigorous safety trials and be tested in humans, as opposed to just samples of their blood. But as of now, the treatment shows promise for aiding allergy sufferers. For people who have allergies, ranging from mild to life-threatening, this experiments could be a major game changer.